This is a quick summary of the main discovery for each research paper we have published, organized issue by issue. Each key finding is below the article title, with a link to the abstract.
Supplement 1 2018
Estimates of effectiveness and reach for ‘return on investment’ modelling of smoking cessation interventions using data from England
Parameter estimates for the effectiveness and reach of interventions that increase population quit-smoking attempt and success rates can contribute to ROI estimates in support of national or regional policy decisions.
Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation
The economic model, EQUIPTMOD, provides an invaluable tool for assessment of the return on investment of policies aimed at promoting smoking cessation.
A utility of model input uncertainty analysis in transferring tobacco control-related economic evidence to countries with scarce resources: results from the EQUIPT study
Countries with limited research time and resources can adapt the EQUIPTMOD return-on-investment model to their own settings by collecting data on a small number of model inputs.
Estimates of costs for modelling return on investment from smoking cessation interventions
Costs of treating smoking-attributable diseases and implementing smoking cessation interventions vary substantially across Hungary, Netherlands, Germany, Spain and England. Cost estimates can contribute to return on investment estimates in support of national or regional policy decisions.
Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD
According to the EQUIPTMOD modelling tool it would be cost-effective for Spain to expand the reach of existing GP brief interventions for smoking cessation, provide pro-active telephone support, and reimburse smoking cessation medication.
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
Increasing the reach of group-based behavioural support, financial incentives and varenicline for smoking cessation by just 1% of current annual quit attempts would be a cost-effective way to improve the population's health outcomes.
Is it cost-effective to provide internet-based interventions to complement the current provision of smoking cessation services in the Netherlands? An analysis based on the EQUIPTMOD
Providing internet-based smoking cessation interventions to complement the current provision of smoking cessation services could be a cost-saving policy option in the Netherlands.
Cost-effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD
According to the EQUIPTMOD modelling tool, it would be cost-effective for Hungary to start a social marketing campaign and double the reach of current group-based behavioural support therapies and proactive telephone support for smoking cessation.
Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD
Current provision of smoking cessation services in the Netherlands and England can benefit economically from the inclusion of cytisine and increasing the reach of brief physician advice, text-messaging support and group-based therapy.